Ascertainment, meta-analysis and reporting of adverse reactions in clinical trials of antibiotics
Abstract
The ascertainment and analysis of adverse reactions to investigational agents presents a significant challenge because of the infrequency of these events, their subjective nature and the low priority of safety evaluations in many clinical trials. A one year review of antibiotic trials published in medical journals demonstrates the lack of standards in identifying and reporting these potentially fatal conditions. This review also illustrates the low probability of observing and detecting rare events in typical clinical trials which include fewer than 300 subjects. Uniform standards for ascertainment and reporting are suggested which include operational definitions of study subjects. Meta-analysis of selected antibiotic trials using multivariate regression analysis indicates that meaningful conclusions may be drawn from data from multiple studies which are pooled in a scientifically rigorous manner.
Subject Area
Public health
Recommended Citation
Elting, Linda Sterrett, "Ascertainment, meta-analysis and reporting of adverse reactions in clinical trials of antibiotics" (1988). Texas Medical Center Dissertations (via ProQuest). AAI8914290.
https://digitalcommons.library.tmc.edu/dissertations/AAI8914290